Table 1.
Patient baseline demographics and disease characteristics (FAS)
| Treatment-naïve (n = 201) | Previously treated (n = 73) | Overall (n = 274) | |
|---|---|---|---|
| Age, years | 77.6 ± 7.6 | 76.1 ± 8.3 | 77.2 ± 7.8 |
| Female, n (%) | 135 (67.2) | 44 (60.3) | 179 (65.3) |
| Country, n (%) | |||
| Argentina | 163 (81.1) | 33 (45.2) | 196 (71.5) |
| Colombia | 12 (6.0) | 7 (9.6) | 19 (6.9) |
| Costa Rica | 4 (2.0) | 14 (19.2) | 18 (6.6) |
| Mexico | 22 (11.0) | 19 (26.0) | 41 (15.0) |
| BCVA in the study eye, letter score | 48.2 ± 23.5 | 47.7 ± 21.4 | 48.0 ± 22.9 |
| Categorical BCVA letter score, n (%) | |||
| ≥ 70 letters | 42 (20.9) | 14 (19.2) | 56 (20.4) |
| < 70 letters | 159 (79.1) | 59 (80.8) | 218 (79.6) |
| CRT, μm | 378 ± 137 | 400 ± 137 | 385 ± 137 |
Values are mean ± SD unless otherwise stated
BCVA best-corrected visual acuity, CRT central retinal thickness, FAS full analysis set, SD standard deviation